Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
66.80
+1.20 (1.83%)
Jul 24, 2026, 5:29 PM CET

STO:IBT.B Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
--00.080.010.09
Revenue Growth (YoY)
---94.80%541.67%-87.23%-69.87%
Gross Profit
--00.080.010.09
Selling, General & Admin
19.820.1519.313.51--
Research & Development
55.248.85126.05121.1865.8244.67
Total Operating Expenses
7569145.35134.6965.8244.67
Operating Income
-75-69-145.34-134.62-65.81-44.58
Interest Income
567.073.838.4411.550.65-
Interest Expense
-----0.29-0.41
Total Non-Operating Income (Expense)
567.073.838.4411.550.36-0.41
Pretax Income
-71.36-65.17-136.91-123.07-65.45-44.99
Net Income
-71.36-65.17-136.91-123.07-65.45-44.99
Net Income to Common
-71.36-65.17-136.91-123.07-65.45-44.99
Shares Outstanding (Basic)
131312121111
Shares Outstanding (Diluted)
131312121111
Shares Change (YoY)
-8.95%-10.14%--
EPS (Basic)
-5.30-4.84-10.16-9.95-5.83-4.01
EPS (Diluted)
-5.30-4.84-10.16-9.95-5.83-4.01
Free Cash Flow
-56.78-72.34-113.13-101.22-85.8-55.62
Free Cash Flow Per Share
-4.21-5.37-9.15-8.19-7.64-4.95
Gross Margin
--100.00%100.00%100.00%100.00%
Operating Margin
---3633580.00%-174827.00%-548400.00%-47423.40%
Profit Margin
---3422630.00%-159829.00%-545425.00%-47862.80%
FCF Margin
---2828330.00%-131453.00%-714958.00%-59173.40%
EBITDA
-74.18-68.18-144.53-133.8-64.99-43.76
EBITDA Margin
---3613180.00%-173768.00%-541600.00%-46555.30%
EBIT
-75-69-145.34-134.62-65.81-44.58
EBIT Margin
---3633580.00%-174827.00%-548400.00%-47423.40%